These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 23428067

  • 1. Antiplatelet therapy in patients with coronary stent undergoing urologic surgery: is it still no man's land?
    Naspro R, Rossini R, Musumeci G, Gadda F, Pozzo LF.
    Eur Urol; 2013 Jul; 64(1):101-5. PubMed ID: 23428067
    [No Abstract] [Full Text] [Related]

  • 2. Antiplatelet therapy management in patients with coronary stent undergoing vascular surgery.
    Bozzani A, Ferlini M, Rossini R, Musumeci G, Arici V, Bramucci E, Setacci C.
    J Cardiovasc Surg (Torino); 2015 Aug; 56(4):681-3. PubMed ID: 25008060
    [No Abstract] [Full Text] [Related]

  • 3. Should all stent patients have prolonged dual antiplatelet therapy?
    Kirtane AJ, King SB.
    JACC Cardiovasc Interv; 2015 May; 8(6):873-875. PubMed ID: 25999115
    [No Abstract] [Full Text] [Related]

  • 4. The saga of the duration of dual antiplatelet therapy after drug-eluting stent placement.
    Helft G.
    Arch Cardiovasc Dis; 2015 Oct; 108(10):469-71. PubMed ID: 26432274
    [No Abstract] [Full Text] [Related]

  • 5. Outcomes of a preoperative "bridging" strategy with glycoprotein IIb/IIIa inhibitors to prevent perioperative stent thrombosis in patients with drug-eluting stents who undergo surgery necessitating interruption of thienopyridine administration.
    Alshawabkeh LI, Prasad A, Lenkovsky F, Makary LF, Kandil ES, Weideman RA, Kelly KC, Rangan BV, Banerjee S, Brilakis ES.
    EuroIntervention; 2013 Jun 22; 9(2):204-11. PubMed ID: 23454910
    [Abstract] [Full Text] [Related]

  • 6. Outcomes of preoperative bridging therapy for patients undergoing surgery after coronary stent implantation: a weighted meta-analysis of 280 patients from eight studies.
    Warshauer J, Patel VG, Christopoulos G, Kotsia AP, Banerjee S, Brilakis ES.
    Catheter Cardiovasc Interv; 2015 Jan 01; 85(1):25-31. PubMed ID: 24740634
    [Abstract] [Full Text] [Related]

  • 7. Conversations in cardiology: bridging antiplatelet therapy before surgery.
    Kern MJ, Applegate RJ, Bell M, Brilakis ES, Butman SM, Bach RG, Kaul P, Klein LW, Krucoff MW, Moore JA, Price MJ, Rao SV, Stone GW, Uretsky BF.
    Catheter Cardiovasc Interv; 2014 Apr 01; 83(5):748-52. PubMed ID: 24395180
    [Abstract] [Full Text] [Related]

  • 8. Platelet Reactivity: Is There a Role to Switch?
    Aradi D, Merkely B, Komócsi A.
    Prog Cardiovasc Dis; 2015 Apr 01; 58(3):278-84. PubMed ID: 26260612
    [Abstract] [Full Text] [Related]

  • 9. Personalized antiplatelet therapy: the wrong approach?
    Collet JP, Montalescot G.
    Arch Cardiovasc Dis; 2013 Oct 01; 106(10):481-6. PubMed ID: 24080323
    [No Abstract] [Full Text] [Related]

  • 10. Stent thrombosis: a clinical perspective.
    Claessen BE, Henriques JP, Jaffer FA, Mehran R, Piek JJ, Dangas GD.
    JACC Cardiovasc Interv; 2014 Oct 01; 7(10):1081-92. PubMed ID: 25341705
    [Abstract] [Full Text] [Related]

  • 11. Prognostic implications of early and long-term bleeding events in patients on one-year dual antiplatelet therapy following drug-eluting stent implantation.
    Musumeci G, Rossini R, Lettieri C, Capodanno D, Romano M, Rosiello R, Guagliumi G, Valsecchi O, Gavazzi A, Angiolillo DJ.
    Catheter Cardiovasc Interv; 2012 Sep 01; 80(3):395-405. PubMed ID: 22109961
    [Abstract] [Full Text] [Related]

  • 12. Duration of Dual Anti-Platelet Therapy Post-Percutaneous Intervention: Is There A Correct Amount of Time?
    Garratt KN.
    Prog Cardiovasc Dis; 2015 Sep 01; 58(3):285-98. PubMed ID: 26343876
    [Abstract] [Full Text] [Related]

  • 13. Dual antiplatelet therapy after drug-eluting stents: defining the proper duration.
    Park SJ, Kang SM, Park DW.
    Coron Artery Dis; 2014 Jan 01; 25(1):83-9. PubMed ID: 24322887
    [Abstract] [Full Text] [Related]

  • 14. The optimal management of patients on oral anticoagulation undergoing coronary artery stenting. The 10th Anniversary Overview.
    Rubboli A, Faxon DP, Juhani Airaksinen KE, Schlitt A, Marín F, Bhatt DL, Lip GY.
    Thromb Haemost; 2014 Dec 01; 112(6):1080-7. PubMed ID: 25298351
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation.
    Helft G.
    Arch Cardiovasc Dis; 2013 May 01; 106(5):271-3. PubMed ID: 23769401
    [No Abstract] [Full Text] [Related]

  • 20. Meta-analysis of duration of dual antiplatelet therapy in patients with acute coronary syndrome after percutaneous coronary intervention.
    Khan SU, Riaz IB, Rahman H, Lone AN, Raza M, Khan MS, Riaz A, Kaluski E.
    Eur J Prev Cardiol; 2019 Mar 01; 26(4):429-432. PubMed ID: 30152256
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.